|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|
| Cash Flows from Operating Activities: | |
| Net income (loss | |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| Gain on issuance of working capital warrants | |
| Change in fair value of derivative warrant liabilities | |
| Transaction costs associated with issuance of warrants | |
| Income from investments held in Trust Account | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | |
| Accounts payable | |
| Accrued expenses | |
| Net cash used in operating activities | |
| Cash Flows from Investing Activities: | |
| Cash deposited in Trust Account | |
| Net cash used in investing activities | |
| Cash Flows from Financing Activities: | |
| Proceeds from promissory note issued to related party | |
| Payment of promissory note issued to related party | |
| Proceeds received from initial public offering, gross | |
| Proceeds from issuance of working capital loan warrants | |
| Offering costs paid | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash - beginning of the period | |
| Cash - end of the period | |
| Supplemental disclosure of noncash investing and financing activities: | |
| Offering costs included in accrued expenses | |
| Offering costs paid by related party under promissory note | |
| Deferred underwriting commissions in connection with the initial public offering |
Loading...
